BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2118860)

  • 1. Use of buserelin acetate in an in vitro fertilization program: a comparison with classical clomiphene citrate-human menopausal gonadotropin treatment.
    Lejeune B; Barlow P; Puissant F; Delvigne A; Vanrysselberge M; Leroy F
    Fertil Steril; 1990 Sep; 54(3):475-81. PubMed ID: 2118860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG.
    Van der Elst J; Van den Abbeel E; Camus M; Smitz J; Devroey P; Van Steirteghem A
    Hum Reprod; 1996 Oct; 11(10):2097-106. PubMed ID: 8943509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program.
    Abdalla HI; Ahuja KK; Leonard T; Morris NN; Honour JW; Jacobs HS
    Fertil Steril; 1990 Mar; 53(3):473-8. PubMed ID: 2106453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization.
    Macnamee MC; Howles CM; Edwards RG; Taylor PJ; Elder KT
    Fertil Steril; 1989 Aug; 52(2):264-9. PubMed ID: 2502441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term utilization of a gonadotropin-releasing hormone agonist (buserelin) for induction of ovulation in an in vitro fertilization program.
    Loumaye E; de Cooman S; Anoma M; Psalti I; Depreester S; Schmit M; Thomas K
    Ann N Y Acad Sci; 1988; 541():96-102. PubMed ID: 3143299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian hyperstimulation for in vitro fertilization preceded by prolonged administration of a gonadotropin-releasing hormone agonist.
    Tanbo T; Dale PO; Abyholm T
    Acta Obstet Gynecol Scand; 1990; 69(4):333-7. PubMed ID: 2123069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The results of an in vitro fertilization program: two regimens of superovulation.
    Grochowski D; Wołczyński S; Kuczyński W; Kulikowski M; Szamatowicz M
    Gynecol Endocrinol; 1995 Mar; 9(1):59-62. PubMed ID: 7793301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
    MacLachlan V; Besanko M; O'Shea F; Wade H; Wood C; Trounson A; Healy DL
    N Engl J Med; 1989 May; 320(19):1233-7. PubMed ID: 2496310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The beneficial effects of short-term administration of a LHRH agonist (buserelin) in in vitro fertilization].
    Loumaye E; de Cooman S; Psalti I; Schrurs B; Adam T; Depreester S; Thomas K
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(8):1081-7. PubMed ID: 3148649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of a short regimen of buserelin, a gonadotrophin-releasing hormone agonist, and human menopausal gonadotrophin in assisted conception cycles.
    Owen EJ; Davies MC; Kingsland CR; Jacobs HS; Mason BA
    Hum Reprod; 1989 Oct; 4(7):749-53. PubMed ID: 2514192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should gonadotropin-releasing hormone down-regulation therapy be routine in in vitro fertilization?
    Harrison RF; Kondaveeti U; Barry-Kinsella C; Gordon A; Drudy L; Cottell E; Hennelly B; Frankish A; Unwin A
    Fertil Steril; 1994 Sep; 62(3):568-73. PubMed ID: 8062954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.
    Peeraer K; Debrock S; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Mol BW; Spiessens C; De Neubourg D; D'Hooghe TM
    Hum Reprod; 2015 May; 30(5):1079-88. PubMed ID: 25788569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative success of gonadotropin-releasing hormone analogue, clomiphene citrate, and gonadotropin in 1,099 cycles of in vitro fertilization.
    Dor J; Ben-Shlomo I; Levran D; Rudak E; Yunish M; Mashiach S
    Fertil Steril; 1992 Nov; 58(5):986-90. PubMed ID: 1426387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFT.
    Smitz J; Devroey P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
    Hum Reprod; 1988 Oct; 3 Suppl 2():35-8. PubMed ID: 3147990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian stimulation in previous failures from in-vitro fertilization: distinction of two groups of poor responders.
    Tanbo T; Abyholm T; Bjøro T; Dale PO
    Hum Reprod; 1990 Oct; 5(7):811-5. PubMed ID: 2125056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of an GnRH analogue for induction of gonadotrophin ovulatory surge in cycles stimulated with clomiphene citrate and menopausal gonadotropin in an in vitro fertilization program].
    Wołczyński S; Kulikowski M; Syrewicz M; Kuczyński W; Grochowski D; Sola E; Szamatowicz M
    Ginekol Pol; 1994 Oct; 65(10):573-7. PubMed ID: 7729718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of human menopausal gonadotropin stimulation with and without clomiphene for in-vitro fertilisation in poor-responders.
    Oride A; Kanasaki H; Miyazaki K
    J Obstet Gynaecol; 2015 Feb; 35(2):163-7. PubMed ID: 25058620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of endometrial histology, morphometry, and ultrasound appearance after different stimulation protocols for in vitro fertilization.
    Rogers PA; Polson D; Murphy CR; Hosie M; Susil B; Leoni M
    Fertil Steril; 1991 Mar; 55(3):583-7. PubMed ID: 1900484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate) for folliculogenesis in routine in vitro fertilization patients.
    Polson DW; MacLachlan V; Krapez JA; Wood C; Healy DL
    Fertil Steril; 1991 Sep; 56(3):509-14. PubMed ID: 1909978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of human menopausal gonadotropin, clomiphene citrate, and combined human menopausal gonadotropin-clomiphene citrate stimulation protocols for in vitro fertilization.
    Diamond MP; Hill GA; Webster BW; Herbert CM; Rogers BJ; Osteen KG; Maxson WS; Vaughn WK; Wentz AC
    Fertil Steril; 1986 Dec; 46(6):1108-12. PubMed ID: 2946610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.